Change of circulating tumor cells before and after neoadjuvant chemotherapy in patients with primary breast cancer

被引：1
|
作者：
Horiguchi, J.
Takata, D.
Rokutanda, N.
Nagaoka, R.
Tokiniwa, H.
Tozuka, K.
Sato, A.
Kikuchi, M.
Oyama, T.
Takeyoshi, I.
机构：
[1] Gunam Univ Hosp, Gunma, Japan
[2] Gunma Univ Hosp, Gunma, Japan
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS12-P3-06-29
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-06-29
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Heterogeneity of circulating tumor cells in primary breast cancer patients
    Bystricky, Branislav
    Karaba, Marian
    Benca, Juraj
    Vavrova, Ludmila
    Markus, Jan
    Konecny, Michal
    Pindak, Daniel
    Sufliarsky, Jozef
    Mardiak, Jozef
    Mego, Michal
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Circulating tumor cell subset analysis to assess lifestyle interventions for breast cancer patients after neoadjuvant chemotherapy
    Gao, H.
    Cohen, E. N.
    Yang, P.
    Austin, T. A.
    Haddad, R.
    Wu, Q.
    Basen-Engquist, K. M.
    Ochoa, J. M.
    Arun, B. K.
    Perkins, G. H.
    Tin, S.
    Vallone, V. S.
    Mallaiah, S. G.
    West, C. B.
    Thompson, A. S.
    Chaoul, A.
    Cohen, L.
    Reuben, J. M.
    CANCER RESEARCH, 2019, 79 (04)
  • [33] Correlation of Methylated Circulating Tumor DNA With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
    Takahashi, Hiroyo
    Kagara, Naofumi
    Tanei, Tomonori
    Naoi, Yasuto
    Shimoda, Masafumi
    Shimomura, Atsushi
    Shimazu, Kenzo
    Kim, Seung Jin
    Noguchi, Shinzaburo
    CLINICAL BREAST CANCER, 2017, 17 (01) : 61 - +
  • [34] The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer
    Camara, O.
    Rengsberger, M.
    Egbe, A.
    Koch, A.
    Gajda, M.
    Hammer, U.
    Jorke, C.
    Rabenstein, C.
    Untch, M.
    Pachmann, K.
    ANNALS OF ONCOLOGY, 2007, 18 (09) : 1484 - 1492
  • [35] Circulating tumor cells may serve as a supplement to RECIST in neoadjuvant chemotherapy of patients with locally advanced breast cancer
    Ji Wang
    Xinyang Wang
    Rui Chen
    Mengdi Liang
    Minghui Li
    Ge Ma
    Tiansong Xia
    Shui Wang
    International Journal of Clinical Oncology, 2022, 27 : 889 - 898
  • [36] Heterogeneous circulating tumor cells correlate with responses to neoadjuvant chemotherapy and prognosis in patients with locally advanced breast cancer
    Ge Ma
    Jingyi Wang
    Jingyue Fu
    Rui Chen
    Mengdi Liang
    Minghui Li
    Tiansong Xia
    Xiaoan Liu
    Shui Wang
    Breast Cancer Research and Treatment, 2023, 201 : 27 - 41
  • [37] Circulating tumor cells may serve as a supplement to RECIST in neoadjuvant chemotherapy of patients with locally advanced breast cancer
    Wang, Ji
    Wang, Xinyang
    Chen, Rui
    Liang, Mengdi
    Li, Minghui
    Ma, Ge
    Xia, Tiansong
    Wang, Shui
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (05) : 889 - 898
  • [38] Heterogeneous circulating tumor cells correlate with responses to neoadjuvant chemotherapy and prognosis in patients with locally advanced breast cancer
    Ma, Ge
    Wang, Jingyi
    Fu, Jingyue
    Chen, Rui
    Liang, Mengdi
    Li, Minghui
    Xia, Tiansong
    Liu, Xiaoan
    Wang, Shui
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (01) : 27 - 41
  • [39] Circulating Tumor Cells in Patients with Breast Cancer: Monitoring Chemotherapy Success
    Usiakova, Zuzana
    Mikulova, Veronika
    Pinterova, Daniela
    Brychta, Milan
    Valchar, Josef
    Kubecova, Martina
    Tesarova, Petra
    Bobek, Vladimir
    Kolostova, Katarina
    IN VIVO, 2014, 28 (04): : 605 - 614
  • [40] Tumor marking before primary chemotherapy for breast cancer
    Reynolds, HE
    Lesnefsky, MH
    Jackson, VP
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1999, 173 (04) : 919 - 920
12345